SFA — Sopharma AD Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMid CapSuper Stock

Annual balance sheet for Sopharma AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	37.7	19.9	129	35.6	71.6
Net Total Accounts Receivable
Net Total Receivables	253	247	290	323	467
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	571	572	787	849	1,090
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	362	376	358	392	413
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,205	1,254	1,514	1,796	2,080
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	424	407	609	771	841
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	558	549	776	978	1,128
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Total Equity	647	705	738	818	951
Total Liabilities & Shareholders' Equity	1,205	1,254	1,514	1,796	2,080
Total Common Shares Outstanding